Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
Clinical trial NCT05369065 · RECRUITING
Trial details
- NCT number
- NCT05369065
- Sponsor
- Neurotronic, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2025-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.